Key Takeaways
- •Peptides form from amino acids joined by peptide bonds.
- •Peptide drugs show high biological activity and lower toxicity than small molecule drugs.
- •Targeted peptides bind to specific cell surface receptors or molecules for accurate drug delivery.
Peptides Overcome Key Drug Delivery Challenges
Peptides form from amino acids joined by peptide bonds. They provide high efficiency, low toxicity, and strong specificity. Recent research highlights their role in drug delivery due to traits like targeted delivery, cell penetration, environmental responsiveness, and self-assembly.
Peptide drugs show high biological activity and lower toxicity than small molecule drugs. Yet they face issues such as breakdown by gastrointestinal enzymes, short half-lives, and limited cell penetration. Solutions include structural changes, nanotechnology, and drug-device combinations to boost stability and performance. Check the Peptide Glossary for definitions of these terms.
Targeted Peptides for Precise Delivery
Targeted peptides bind to specific cell surface receptors or molecules for accurate drug delivery. For instance, RGD peptides recognize the integrin αvβ3 receptor to aid selective anti-tumor drug delivery. NGR peptides also support receptor-mediated targeting.
T7 peptides target transferrin receptors to cross the blood-brain barrier for neurodegenerative disease treatments. PD-L1 targeting peptides improve immunotherapy through immuno-targeting. These approaches ensure drugs reach intended sites with precision.
Cell-Penetrating Peptides Boost Intracellular Access
Cell-penetrating peptides (CPPs) help drugs pass cell membranes into the cytoplasm. This proves vital for intracellular-acting drugs like nucleic acids and proteins. CPPs interact with membranes to promote endocytosis or direct transport, raising drug levels inside cells.
Cationic CPPs such as TAT and Penetratin use electrostatic interactions with membranes. Hydrophobic CPPs like TP10 and C105Y enable delivery via membrane fusion. Chimeric CPPs, including Pep-1, blend cationic and hydrophobic features for better efficiency. CPP systems serve small molecules, proteins, peptides, and nucleic acids in cancer, gene therapy, and vaccines.
Responsive Peptides Control Drug Release
Responsive peptides change structure or function in specific conditions like pH, temperature, or enzyme levels for controlled release. His-modified peptides respond to acidic tumor environments to free drugs. MMP-2 recognition peptides break down in high-MMP-2 tumor tissues.
These peptides adapt to physiological cues. They enable site-specific activation and reduce off-target effects.
Self-Assembling Peptides Form Drug Carriers
Self-assembling peptides create nanostructures like nanoparticles, nanofibers, and nanotubes. These improve peptide drug stability and allow sustained release. Peptide hydrogels trap drugs in nanonetworks for local, prolonged delivery.
Applications cover tissue engineering and regenerative medicine, such as growth factor-loaded hydrogels for wound healing. Self-assembly occurs spontaneously under conditions like certain pH, temperature, or ion strength. Types include β-sheet, α-helix, and amphipathic peptides with unique assembly traits. Use the Half-Life Calculator to model peptide durations in such systems.
Peptide nanofibers offer biocompatibility and mechanical strength for controlled release in tissue engineering. Nanovesicles encapsulate hydrophilic or hydrophobic drugs to enhance stability and bioavailability.
Modifications and Combinations Enhance Performance
End-terminal changes like N-acetylation and C-amidation extend in-body half-lives and stability. GLP-1 receptor agonists fuse with albumin to prolong plasma half-life. Side chain swaps boost solubility and binding. Backbone alterations resist enzymatic degradation.
PEGylation attaches polyethylene glycol to lengthen half-life, raise bioavailability, and lower immunogenicity. Peptide-nanocarrier pairs include liposome-peptide systems where RGD-modified liposomes target better. Polymeric nanoparticles like PLGA-peptide versions suit sustained delivery. Gold nanoparticles (AuNPs) and quantum dots (QDs) with peptides combine imaging and therapy.
Elastin-like peptides (ELP), temperature-responsive, form smart systems. Microneedles enable transdermal delivery for better bioavailability and compliance. Patches provide localized treatment for skin issues or pain. Iontophoresis and ultrasound increase skin or mucosa permeability.
Future Prospects for Peptide Delivery
Peptides hold wide promise in drug delivery thanks to targeted, penetrating, responsive, and assembling properties. Challenges remain, including high costs, poor stability, and rapid metabolism. Ongoing work targets novel modifications with non-natural amino acids for longer half-lives, peptide synergies with liposomes, nanoparticles, or hydrogels, and clinical translation for practical drugs. Explore our Free peptide tools for stability and dosage planning.
